Fetal Penile Length and Corpus Cavernosum Length - Normal Measurement Via Ultrasound

Fetal Penis Length Clinical Trial

Official title:

Prospective Cross-sectional Study of Fetal Penis and Corpus Cavernosum Length

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01114867
• Other study ID #: TASMC-10-YH-0128-CTIL
• Status: Not yet recruiting
• Phase: N/A
• First received: April 29, 2010
• Last updated: March 26, 2014
• Start date: October 2010

Study information

• Verified date: April 2010
• Source: Tel-Aviv Sourasky Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Ministry of Health
• Study type: Observational

Clinical Trial Summary

Hypothesis: Measurement of fetal penis length by ultrasound may be inaccurate when measured from the scrotum to the penile tip. we will provide normal values of penile length measured from the penile tip to the abdominal wall and measuring the corpus cavernosum length.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 200
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 14 Weeks to 34 Weeks

Eligibility

Inclusion Criteria:

• pregnant women at 14th through 34th week gestation,

• routine ultrasound not preformed for anomalies at the genitourinary system,

• estimated fetal weight corresponds to gestational age.

Exclusion Criteria:

• women who's fetuses are suspected to be with fetal growth retardation,

• women who's fetuses are suspected to be with genitourinary anomaly.

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Fetal Penis Length

Locations

Country	Name	City	State
Israel	Ultrasound Unit in OBGYN, Soraski Medical Center	Tel-Aviv

Sponsors (1)

Lead Sponsor	Collaborator
Tel-Aviv Sourasky Medical Center

Country where clinical trial is conducted

Israel,